$VEEV

Faddis Jonathan sold $1.6M of VEEV

Faddis Jonathan (SVP, Gen. Counsel, Secretary) sold 5,198 shares of VEEVA SYSTEMS INC (VEEV) at an average of $299.72 ($298.19–$300.14, $1.56M total) across 3 trades on 2026-10-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Faddis Jonathan
Published Oct 16, 2026, 8:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VEEV
Bearish
medium confidence
Mentioned
$VEEV
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VEEVBearishLow
01

Why it matters

The filing adds a new data point on insider activity for Veeva Systems.

02

Market read

A senior officer's sale may prompt short‑term price caution but is unlikely to drive major moves.

03

What to watch

The 10b5‑1 plan pre‑arranged nature may reduce informational content of the trade.

Relevance 5/10Novelty 4/10Timing: post‑market filing

Background

SEC Form 4 disclosures provide the first public record of insider transactions.

Company-level read

Ticker impact

$VEEVBearishMedium confidence
Context

Form 4 filing shows SVP and General Counsel Jonathan Faddis sold 5,198 shares for $1.56M via a 10b5-1 plan.

Expected impact

likely slight downward pressure as market prices in the insider sell.

Evidence & confidence

Sale size is modest relative to market cap, but the insider is a senior officer; such sales often prompt short‑term caution.

Market effects

Minimal impact on the broader health‑tech sector.

No significant regional effect.

Limited to Veeva investors.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Veeva Systems Inc.

    Provider of cloud‑based software for the life‑sciences industry.

  • Jonathan Faddis

    Senior Vice President, General Counsel, and Secretary at Veeva.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VEEVHigh

Veeva Systems (VEEV) Stock Trades Up, Here Is Why

Veeva Systems (VEEV) stock rose 2.8% after expanding its partnership with IQVIA, which adopted Veeva's clinical operations software. The company reported Q2 revenue of $928M, up 17.6% YoY, beating estimates. VEEV raised full-year revenue guidance to $3.68B and adjusted earnings outlook to $9.21 per share. The stock is up 37% YTD and hit a 52-week high.

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVHighAI 8/10

Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.

Veeva Systems reported a 37% increase in net income to $273.4M and raised fiscal 2027 revenue guidance to $3.682B-$3.687B. Michael Burry trimmed his position but remains bullish, citing the company's intrinsic value and growth potential. Analysts expect Q3 EPS of $1.68 and have raised price targets, with a consensus 'Moderate Buy' rating and $292.52 average target.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.

$VEEVHighAI 8/10

Watch Veeva, CrowdStrike, and More

Veeva Systems (VEEV) reported Q2 non-GAAP EPS of $2.35, revenue growth of 17.6% Y/Y to $928M, and raised its Q3 revenue forecast. CrowdStrike (CRWD) posted 25.6% Y/Y revenue growth to $1.47B. Dycom Industries (DY) fell 11.6% despite 45.6% Y/Y revenue growth to $2.01B due to segment pressures and higher costs.